Physician of the Year Award
David E. Bernstein, MD, AGAF, FACP, FACG is Clinical Professor of Medicine at the Albert Einstein College of Medicine and Professor of Medicine at the Hofstra North Shore Long Island Jewish School of Medicine. He is the Chief of Hepatology and Center for Liver Disease at the North Shore-LIJ Health System.
After earning his medical degree from the State University of New York at Stony Brook, Dr. Bernstein completed his internship and medical residency at Montefiore Medical Center in Bronx, NY. He subsequently completed fellowships in gastroenterology and hepatology at University of Miami-Affiliated Hospitals in Miami, Florida under the direction of Dr Eugene Schiff.
Dr. Bernstein is the immediate past Governor for the Long Island District of the American College of Gastroenterology. He is the President and Treasurer of the Bockus International Society of Gastroenterology and a former President of the New York Gastrointestinal Society. He is a member of the Medical Advisory Board of the American Liver Foundation, a consultant to the New York State Department of Health and a member of the New York State Department of Health Office Based Surgery Advisory Board.
Dr. Bernstein has conducted extensive research on the safety and efficacy of treatments for various types of chronic liver diseases such hepatitis B, hepatitis C and on coagulation disorders in liver disease. He is the author of many peer-reviewed articles and book chapters and a frequent guest lecturer both nationally and internationally. He is a reviewer for multiple national journals and has served on multiple committees for the American Association for the Study of Liver Diseases and the American College of Gastroenterology.
The American Liver Foundation, Greater New York Division is proud to honor Dr. Bernstein this year.
President, U.S. Pharmaceuticals
Habib Dable is President of U.S. Pharmaceuticals for Bayer Pharmaceuticals Inc., a role he has held since October 2015.Most recently, Habib was global head of specialty medicine for Bayer Pharmaceuticals, a role he held since 2013 and in which was responsible for overseeing four therapeutic areas for the company – hematology, oncology, ophthalmology, and neurology.
Habib began his career at Bayer in 1994 as a sales representative in Canada, where he later and moved on to various sales and marketing roles with increasing management responsibility. He then spent two years at Bayer HealthCare’s office in Osaka, Japan as Head of Strategic Planning, before moving to the United States and serving as Director of International Sales and Marketing. He was later appointed Vice President and Regional Business Unit Head responsible for Latin America, Canada, Asia Pacific and Japan.
From 2008 to 2012, Habib headed Bayer’s global therapeutic area team for Neurology / Ophthalmology, and he was Vice President for Ophthalmology and headed the global launch team for EYLEA® (aflibercept), the company’s treatment for macular degeneration.
Habib earned a Master’s of Business Administration from the University of New Brunswick in Canada, where he also completed his undergraduate study. He is married with two children, and resides in New Jersey. Habib’s personal interests include jogging, squash, golf, youth hockey and the classic English card game, whist.